Showing 1 - 10 of 130,875
Persistent link: https://www.econbiz.de/10010417576
Persistent link: https://www.econbiz.de/10011886822
Persistent link: https://www.econbiz.de/10011460538
CHQ location and composition affect the innovation outcomes of these partners. In a study of 36 incumbent pharmaceutical … corporations in 377 strategic alliances with 143 VC-backed biotechnology startups, we leverage detailed hand-collected data on CHQ … the literatures on both CHQ design and technology alliances. …
Persistent link: https://www.econbiz.de/10012131396
pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the …
Persistent link: https://www.econbiz.de/10013233843
pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the …
Persistent link: https://www.econbiz.de/10012469083
This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...
Persistent link: https://www.econbiz.de/10011372508
open innovation within technology clusters. Strategic partnerships in the biotechnology industry allow new technology based …Purpose: New technology based firm (NTBF) survival and growth are connected with strategic partnering alliances and … partnerships and open innovation on the success of new biotechnology firms in Belgium by developing multiple case studies of firms …
Persistent link: https://www.econbiz.de/10011325693
Persistent link: https://www.econbiz.de/10011598745
Persistent link: https://www.econbiz.de/10011866498